MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...
Impulse Dynamics, developer of the revolutionary Cardiac Contractility Modulation (CCM) technology for treatment of Chronic Heart Failure (CHF), announced today that the company has closed a $45 ...
MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, is pleased to announce that it has successfully completed ...
MARLTON, N.J.--(BUSINESS WIRE)--Impulse Dynamics, Inc., a company dedicated to improving the lives of people with heart failure, today announced its innovative CCM ® therapy delivered by the Optimizer ...
MOUNT LAUREL, N.J.--(BUSINESS WIRE)--Impulse Dynamics, developer of Optimizer ® Smart System for delivering CCM™ therapy, announced the completion of an $80.25 million Series D financing with new ...
MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide ...
MARLTON, N.J., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today the appointment ...
MARLTON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership ...
Marlton, NJ, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud to announce that it ...
Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and CCM therapy has been published in more than 120 peer-reviewed journal articles. About ...